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Abstract: The rapid spread of SARS-CoV-2 has activated the world’s “emergency breaks”, forcing a
slowdown of unprecedented magnitude. As a new temporary “normal” settles in, healthcare systems are
making enormous efforts to adjust and mitigate the damage. These adaptation processes accelerate the
use of health technologies that were on previously slow adoption paths, including telehealth. Telehealth,
or telemedicine, is the use of information and communication technology to provide remote care, outside
traditional healthcare contexts [1]. Disrupted healthcare systems and the need for physical distancing
seem to open a window of opportunity for a broader exposure to telehealth solutions, many of which might
have the potential to improve care long after the pandemic passes. As the evidence on the effectiveness, as
well as cost-effectiveness of telemedicine, is mounting, harnessing its benefits post-COVID-19 will require
careful consideration of arising opportunities, as well as timely, proactive action on existing challenges
[1–5].
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The rapid spread of SARS-CoV-2 has activated the world’s
“emergency breaks”, forcing a slowdown of unprecedent-
ed magnitude. As a new temporary “normal” settles in,
healthcare systems are making enormous efforts to adjust
and mitigate the damage. These adaptation processes ac-
celerate the use of health technologies that were on pre-
viously slow adoption paths, including telehealth. Tele-
health, or telemedicine, is the use of information and
communication technology to provide remote care, outside
traditional healthcare contexts [1].
Disrupted healthcare systems and the need for physical dis-
tancing seem to open a window of opportunity for a broad-
er exposure to telehealth solutions, many of which might
have the potential to improve care long after the pandem-
ic passes. As the evidence on the effectiveness, as well as
cost-effectiveness of telemedicine, is mounting, harnessing
its benefits post-COVID-19 will require careful consider-
ation of arising opportunities, as well as timely, proactive
action on existing challenges [1–5].
A window of opportunity
Compared with other European countries, Switzerland of-
fers a relatively mature telemedical ecosystem. Nonethe-
less, the provision of telehealth services is primarily lim-
ited to some of the country’s large telemedical providers,
reporting about 2.5 million annual consultations [6]. On
the other hand, the uptake of telemedicine by the wider
Swiss medical community (e.g., general practitioners) has
remained rather stagnant [6]. How has this changed since
COVID-19 started spreading?
With our health system focusing on COVID-19 damage,
physical proximity is being replaced by distancing and lim-
ited access to certain types of care, aiming to safeguard
physical space, minimise nosocomial SARS-CoV-2 infec-
tions, and reduce exposure risk related to travel and public
transport [7]. During restriction measures, providers and
patients alike will have to balance between providing or
receiving care and minimising risk. This paradigm shift
forces a re-evaluation of the patient-doctor relationship and
highlights the need for alternative modes to access care,
including nonpharmacological and complementary thera-
pies. The longer the pandemic lasts, the likelier it is that
this need will increase overall readiness for exploring and
experimenting with telemedical solutions, especially after
the limits of telephone consultations become apparent [8].
This generates a momentum for telehealth suppliers and
advocates, allowing them to prove the direct value of the
very products they have been long trying to establish.
In fact, the deployment of telehealth during this crisis can
be manifold. Tele-triaging enables the remote pre-screen-
ing of potentially infected patients and eliminates unnec-
essary transmission risks [9, 10]. Using artificial-intelli-
gence-driven chatbots, such as the Swiss-Italian project
COVID-Guide, symptomatic patients can rapidly self-as-
sess their health status and receive recommendations on
how to proceed [11]. Once a mild case is confirmed (or
suspected), telemonitoring offers a safe and reliable alter-
native for overseeing disease progress. Breathlessness and
anxiety can be assessed using audiovisual cues, oropha-
ryngeal inflammation and skin colour changes using video
recordings, and vital signs using wearable device readings
[12]. The use of wearables and other commercial self-mon-
itoring devices does not come without challenges and un-
certainties [12]. There is an abundance of these technolo-
gies, most of which are not approved medical devices,
differ in their measuring accuracy and make any judge-
ment on their validity difficult. Nonetheless, for the chron-
ically ill patients, who face reduced access to their routine
care (e.g., physiotherapy and other nonpharmacological,
medical or complementary therapies), telemedicine can fill
the gaps and potentially avert deteriorating physical and
mental outcomes [5, 13, 14]. Prerequisite for this is that
telehealth is utilised by a wider range of healthcare profes-
sionals (e.g., physiotherapists or psychotherapists) than it
currently is.
Acknowledging these opportunities, as well as the likely
scenario of future COVID-19 waves, Switzerland is lob-
bying for increased use of its already well-established
telemedical infrastructure. The Swiss association of med-
ical doctors (FMH) partnered up with a video conference
provider, enabling access to free and relatively simple re-
mote care services, while also providing a transparent ser-
vice communication channel for other telehealth manu-
facturers [15]. Experts agree that telehealth solutions, if
adopted properly, can contribute towards flattening the
curve of current and future COVID-19 epidemic waves.
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Harnessing these opportunities, during and after the crisis,
requires targeted and proactive action on remaining chal-
lenges.
Understanding the challenges
Although COVID-19 likely increases exposure to tele-
health, the long-term willingness to use telemedical solu-
tions largely depends on addressing some of the barriers
that healthcare providers face. Swiss doctors perceive
some of the main health digitalisation hurdles to be (1) the
lack of interoperability with their own systems, (2) secu-
rity and liability concerns, (3) the inadequate representa-
tion of digital services in reimbursement tariffs, as well as
(4) concerns about too much or too little work [16]. Uncer-
tainties around reimbursement and liability might well be
due to inadequate communication of existing regulations,
and security concerns are potentially fuelled by the scarci-
ty of simple solutions that still fully address data protection
and privacy [16]. This also holds for applications listed in
the recent COVID-19-related communication of the FMH
[15]. The lack of fully transparent risk assessments and ad-
equate security functionalities (e.g., mandatory password
protections) for the listed applications leaves room for im-
provement. In addition, consideration of the demograph-
ics of Swiss doctors suggests that some may lack the nec-
essary digital affinity and possibly the technical skills for
the adoption of telehealth, which also is the case in other
healthcare systems [1, 7, 16, 17]. Added to that, many of
the existing solutions, including some that were listed in
the recent FMH communication, are still subject to techni-
cal, usability and resource barriers (e.g., limited to a cer-
tain internet browser, requiring downloads and monthly
subscriptions) [15]. In combination, perceived barriers and
digital literacy gaps understandably feed scepticism and re-
sistance.
On the patient side, two remaining and yet not adequately
addressed challenges are rooted in the digital divide and
mistrust. The digital divide describes a systematic gap be-
tween those who benefit more and those who benefit less
from digitalisation processes. In health, the current divide
is based on knowledge and self-efficacy differences re-
garding technology use, as well as on overall health liter-
acy gaps, dividing those who are able to utilise technolo-
gy for improving their health and those who are not [18].
Being older, of lower socioeconomic status, a minority or
of lower educational background are, amongst others, key
drivers of that divide [1]. In parallel, the Swiss public’s
scepticism on data use, privacy and security seems to be
on an overall increase, naturally blurring trust and the per-
ceived value of health technology [19].
With a focus on patients and providers, the contextual lim-
itations of our current telehealth ecosystems tend to be
overlooked. Although we overemphasise the effectiveness
and efficiency of health digitalisation, we often pay less
attention to the organisational processes. The integration
of telemedicine into routine practice requires substantial
alterations to established workflows and infrastructures,
which present disincentivising time, resource, and flexibil-
ity demands [1, 20]. Healthcare systems are complex and
dynamic, with adaptations taking time and requiring pa-
tience and motivation [9], [20]. All these elements may
pose important barriers to the uptake of new technology,
including telehealth.
Moving forward
In order to enable a broader use (e.g., by general practi-
tioners, physiotherapists), developers, advocates, and pol-
icy-makers need to address the concerns and uncertainties
of healthcare providers. This requires improved awareness
of and access to low-threshold technologies (e.g., secure
video conferencing and chat systems), allowing an integra-
tion that minimises disruption and effort. Some disruption
and effort cannot be entirely eliminated, but may be kept
low through context-sensitive telehealth solutions that are
(1) technically versatile and simple (e.g., no downloads, no
browser restrictions, no lengthy registration procedures),
(2) adjustable to different workflows (e.g., flexible doc-
umentation protocols, rapid switches between on-site and
remote patients) and (3) not bound to direct long-term
commitment (e.g., no annual subscriptions). The security
and privacy regulations of these tools need to be expanded
and communicated transparently, as should reimbursement
and liability policies. Access to free training and targeted
awareness of the fact that telemedicine does not aim to
replace on-site care should be aimed towards healthcare
providers lacking literacy skills and with disproportionate
digitalisation fears. For that, it is key to listen to the con-
cerns and challenges of those providers that have already
started using telemedicine; while learning from their expe-
rience and helping them maintain it.
In order to enable a broader acceptance by patients, and
especially those needing it most (e.g., elderly, chronically
ill people) we require an explicit and targeted nudging to-
wards telehealth. Education and awareness are simple but
powerful tools, especially for those less familiar with tech-
nology. Access to intuitive telemedical software should be
accompanied by simple guidelines on its proper use and
transparent information on privacy and security. Providers
that offer telemedicine should ensure that these services
are inclusive and clearly communicated to those patents
who might be most affected by COVID-19’s disruptions.
During the crisis, known technology that is currently also
employed by the elderly to stay in touch with close ones,
such as Skype, can be leveraged to reach patients not ca-
pable of or unwilling to try other technologies. This is
certainly not an advisable long-term solution, as many
of these widely used video communication systems are
not designed for confidential medical consultations. Post-
COVID-19, it would be wiser to leverage that increased
technology exposure for introducing previously “hard-to-
reach” patients to safe and simple telehealth solutions.
In conclusion, the longer the epidemic lasts, the stronger
will the need for telehealth be, especially for the most vul-
nerable among us. The need for physical distancing will
keep pushing telehealth into the consciousness and expe-
rience sphere of healthcare providers and patients alike.
In parallel, it will leave many relying on the use of video
technology for maintaining social interactions. Although
these daily video communication tools may not be secure
enough for confidential patient-doctor communications,
they may contribute to a narrower digital divide, improved
technological skills, and reduced resistance to the use of re-
mote care, opening a window of opportunity for realising
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the advantages of telehealth. However, if we are to main-
tain these beyond COVID-19, we cannot ignore the chal-
lenges that come along. These challenges have to be ad-
dressed in a timely and proactive manner, with the
education of patients and physicians about the safe use of
digital communication tools and video conferencing sys-
tems at their core.
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